Q4 2013 13F Holders as of 31 Dec 2013
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
123,180,519
-
Total 13F shares
-
9,288,823
-
Share change
-
+20,970
-
Total reported value
-
$18,136,605
-
Price per share
-
$1.95
-
Number of holders
-
31
-
Value change
-
+$41,000
-
Number of buys
-
2
Institutional Holders of CATALYST PHARMACEUTICALS, INC. - COMMON STOCK (CPRX) as of Q4 2013
As of 31 Dec 2013,
CATALYST PHARMACEUTICALS, INC. - COMMON STOCK (CPRX) was held by
31 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,288,823 shares.
The largest 10 holders included
FEDERATED INVESTORS INC /PA/, ORBIMED ADVISORS LLC, VANGUARD GROUP INC, Opaleye Management Inc., Ghost Tree Capital, LLC, GEODE CAPITAL MANAGEMENT, LLC, ZACKS INVESTMENT MANAGEMENT, AQR CAPITAL MANAGEMENT LLC, TANAKA CAPITAL MANAGEMENT INC, and Bank of New York Mellon Corp.
This page lists
31
institutional shareholders reporting positions in this security
for the Q4 2013 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.